Biogen Inc (BIIB)
140.86
+3.78
(+2.76%)
USD |
NASDAQ |
Feb 21, 15:56
Biogen Market Cap: 20.62B for Feb. 21, 2025
View 4,000+ Financial Data Types:
Add
Browse
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
Eli Lilly and Co | 785.47B |
AbbVie Inc | 356.37B |
Sage Therapeutics Inc | 448.50M |
Moderna Inc | 13.62B |
Gilead Sciences Inc | 137.01B |
Market Cap Related Metrics
PE Ratio | 12.59 |
PS Ratio | 2.125 |
PEG Ratio | 0.3129 |
Price to Book Value | 1.234 |
Price to Free Cash Flow | 8.172 |
Price | 140.86 |
Earnings Yield | 7.94% |
PEGY Ratio | 0.3129 |
Operating PE Ratio | 9.266 |
Normalized PE Ratio | 11.38 |